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THE QOF
On 1 April 2009, the National Institute of Health and Clinical 
Excellence (NICE) took over a new role in advising on new 
indicators for the NHS Quality and Outcomes Framework 
(QOF) in the United Kingdom. Confirmation of this change 
came  at  the  end  of  a  Department  of  Health  consultation 
with patients, carers, NHS professionals and commissioners 
on  how  the  process  should  work. The  move  is  a  strong 
endorsement of NICE’s expertise, gained over 10 years of 
producing evidence-based guidance. 
A crucial part of the new process is the creation, by NICE, 
of  an  independent  Primary  Care  Quality  and  Outcomes 
Framework Indicator Advisory Committee, which will review 
existing indicators and recommend new ones. [The committee 
will be chaired by Dr Colin Hunter who has worked as a 
General Practitioner in Aberdeenshire for over 20 years. Dr 
Hunter takes up his post having already held a number of high 
profile positions, including Chairman of the Scottish Council 
of the RCGP (1996 – 2000) and as National Co-ordinator of 
Primary Care for NHS Education Scotland (1995 – 2005). 
Dr Hunter was also heavily involved in the original version 
of the QOF, helping to draw up the original outline scheme 
for the framework which was then proposed to the profession 
in 2003.] The membership of the committee, finalised in 
May 2009, includes individuals with experience of primary 
care, (including GPs and nurses) as well as patients, carers 
and social care professionals drawn from Northern Ireland, 
Scotland and Wales as well as England (table I). The process 
is outlined in table II. Involvement of the devolved 
administrations  in  the  new  process  is  very 
important for the changes proposed for the QOF 
to have the optimal impact throughout the UK. 
NICE is currently discussing how this might best 
be achieved in relation, for example, to piloting 
the indicators in a Northern Ireland context. 
While QOF indicators have served to improve 
the quality of primary and community care, and 
encouraged patients to make health changes in 
their lifestyles, the QOF needed to change. The 
Next Stage (Darzi) Review highlighted a need for 
a more open, transparent process for reviewing 
and developing the indicators it uses. A recent 
National  Audit  Office  report  on  GP  contract 
modernisation  recommended  that  indicators 
should  be  based  more  on  outcomes  and  cost 
effectiveness than they are at present.
THE NEW PROCESS
Decisions on QOF indicators have not up to now 
been  informed  by  systematic  information  on 
the cost effectiveness of the interventions under 
consideration. There is evidence that some QOF 
indicators  may  not  always  reflect  the  value  of 
the  indicators  in  terms  of  health  benefit. This 
is why NICE is to oversee a new, independent, 
objective  system  for  the  development  of  new 
indicators and the review of existing ones. The 
system will be based on evidence of clinical and 
cost effectiveness using the same methodological 
approach that informs our other guidance products. 
Table I: 
NICE guidance is a primary source of advice on effective clinical 
and public health practice in the United Kingdom. It forms part of the 
healthcare standards in England and Wales and is generally adopted in 
Northern Ireland but selectively applied in Scotland.































review© The Ulster Medical Society, 2009.
Helping to Provide High Quality Care in Primary Care 83
www.ums.ac.uk
Because NICE is independent, patients, carers, professionals 
and  other  stakeholders  can  have  confidence  in  the  new 
process, which separates the assessment of the evidence for 
reviewing and developing potential new QOF indicators from 
the negotiation and approval of changes to the QOF. Moreover, 
the new committee will meet in public so that anyone with 
an interest in the process can both see, and hear, how the 
indicators emerge. It is important to emphasise, however, that 
NICE’s role is an advisory one. The final decision on which 
new indicators should be retained, which should be removed, 
and which new ones should be included, will still be made by 
NHS Employers, on behalf of the Department of Health, and 
the British Medical Association (BMA). NICE will therefore 
produce an annual ‘menu’ of evidence-based, cost-effective 
indicators. Evidence of clinical effectiveness will be looked at 
initially using NICE guidance, but will also in time draw upon 
a range of accredited sources of evidence through the new 
NHS Evidence service. Where cost effectiveness information 
it is not readily available, a method for drawing some basic 
conclusions will be used to assess the indicator. 
AN OPEN AND TRANSPARENT PROCESS
It is important to ensure that the process is informed by 
stakeholders  with  experience  of  primary  care. As  part  of 
the open and transparent process, consultation documents 
containing the proposals – ranging from proposed topics for 
indicators to how they have been developed – will be available 
to all stakeholders (including patients).   Anyone can submit 
possible clinical and public health indicator topics on the 
NICE website. The Advisory Committee will then use agreed 
criteria  to  prioritise  topics  based  on  evidence  of  clinical 
and cost effectiveness. An external organisation, appointed 
by NICE, will then develop potential new indicators to be 
considered  by  the  independent Advisory  Committee  and 
with the results of piloting and consultation. The total review 
cycle will take around two years but a rolling programme will 
ensure there are new indicators available each year. At the 
moment there are 88 indicators.   These will be reviewed over 
the next three to four years, so NICE will be reviewing 20 to 
30 a year, in addition to a commitment to develop around 10 
new indicators over each QOF review cycle.
High-quality care depends on making decisions based on 
the best available evidence. Placing NICE at the heart of the 
process will ensure that QOF continues to help ensure patients 
get the healthcare that is among the best in the world.
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Table II: 
the QOF indicators process
QOF indicators process flowchart
Stakeholders submit potential clinical and public health 
priority topics via the NICE website

NICE collates information to prioritise new indicators 
based on evidence of clinical and cost-effectiveness

Independent Advisory Committee considers topics for 
inclusion in the QOF

NICE consults on developed indicators

Advisory Committee validates the final proposals

Recommendations published on the NICE website

NHS Employers, on behalf of the Department of Health, 
and the British Medical Association (BMA) decide on 
final indicators to include in the QOF